Stock Research for PSDV

PSDV
Current Price

$1.1000


Latest Update: 2018-02-16 16:00:00

High
$ 1.1000
Low
$ 1.0900
Close
$ 1.1000
Volume
910
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

PSDV Stock Chart & Research Data

The PSDV chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PSDV chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


PSDV Due diligence Resources & Stock Charts

The PSDV stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PSDV Detailed Price Forecast - CNN Money CNN View PSDV Detailed Summary - Google Finance
Yahoo View PSDV Detailed Summary - Yahoo! Finance Zacks View PSDV Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View PSDV Trends & Analysis - Trade-Ideas Barrons View PSDV Major Holders - Barrons
NASDAQ View PSDV Call Transcripts - NASDAQ Seeking View PSDV Breaking News & Analysis - Seeking Alpha
Spotlight View PSDV Annual Report - CompanySpotlight.com OTC Report View PSDV OTC Short Report - OTCShortReport.com
TradeKing View PSDV Fundamentals - TradeKing Charts View PSDV SEC Filings - Bar Chart
WSJ View Historical Prices for PSDV - The WSJ Morningstar View Performance/Total Return for PSDV - Morningstar
MarketWatch View the Analyst Estimates for PSDV - MarketWatch CNBC View the Earnings History for PSDV - CNBC
StockMarketWatch View the PSDV Earnings - StockMarketWatch MacroAxis View PSDV Buy or Sell Recommendations - MacroAxis
Bullish View the PSDV Bullish Patterns - American Bulls Short Pains View PSDV Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View PSDV Stock Mentions - StockTwits PennyStocks View PSDV Stock Mentions - PennyStockTweets
Twitter View PSDV Stock Mentions - Twitter Invest Hub View PSDV Investment Forum News - Investor Hub
Yahoo View PSDV Stock Mentions - Yahoo! Message Board Seeking Alpha View PSDV Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for PSDV - SECform4.com Insider Cow View Insider Transactions for PSDV - Insider Cow
CNBC View PSDV Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PSDV - OTC Markets
Yahoo View Insider Transactions for PSDV - Yahoo! Finance NASDAQ View Institutional Holdings for PSDV - NASDAQ


Stock Charts

FinViz View PSDV Stock Insight & Charts - FinViz.com StockCharts View PSDV Investment Charts - StockCharts.com
BarChart View PSDV Stock Overview & Charts - BarChart Trading View View PSDV User Generated Charts - Trading View


Latest Financial News for PSDV

pSivida to Present at the 2018 BIO CEO & Investor Conference
Posted on Friday February 09, 2018

WATERTOWN, Mass., Feb. 09, 2018-- pSivida Corp., a leader in the development of sustained release drug products and technologies, announced today that Nancy Lurker, President and Chief Executive Officer, ...


PSivida reports 2Q loss
Posted on Wednesday February 07, 2018

On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of 13 cents. The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks ...


pSivida Corp. Reports Second Quarter FY2018 Results; Continues to Achieve Milestones and Timelines
Posted on Wednesday February 07, 2018

Newly Released Second Phase 3 Study Data for Durasert Three-Year Treatment for Posterior Segment Uveitis Shows Positive Efficacy and Safety Profile Maintained at 12 Months. Awaiting FDA Decision to Accept ...


pSivida's Second Phase 3 Study for Durasert™ Three-year Treatment for Posterior Segment Uveitis Maintains Positive Efficacy and Safety Profile at 12 Months
Posted on Wednesday February 07, 2018

Highly Significant Difference Between Durasert and Sham in Prevention of Uveitis Recurrence at 12 Months. Fiscal Q2 2018 Results Conference Call Scheduled for Today at 4:30 p.m. ET. WATERTOWN, Mass., Feb. ...


Somewhat Positive News Coverage Somewhat Unlikely to Impact pSivida (NASDAQ ...
StockNewsTimes - Dec 31, 2017
pSivida logo Media stories about pSivida (NASDAQ:PSDV) have trended somewhat positive this week, Accern Sentiment reports.

B. Riley Comments on pSivida Corp.'s Q3 2018 Earnings (PSDV)
Week Herald - Nov 14, 2017
HC Wainwright set a $5.00 price target on pSivida and gave the company a “buy” rating in a research report on Thursday, February 8th.

Q3 2018 Earnings Forecast for pSivida Corp. Issued By B. Riley (PSDV)
Dispatch Tribunal - Nov 6, 2017
pSivida had a negative net margin of 882.37% and a negative return on equity of 205.82%. An institutional investor recently bought a new position in pSivida stock.
Analyst Research and Recommendations: pSivida Corp. (PSDV), Yield10 Bioscience ... - Analyst Journal

pSivida Corp. Reports Second Quarter FY2018 Results; Continues to Achieve ...
GlobeNewswire (press release) - Feb 7, 2018
“We achieved several milestones in the fiscal second quarter and the past few weeks and continue to make material progress in the transformation of pSivida into a fully integrated commercial stage pharmaceutical enterprise,” commented Nancy Lurker ...

Enter a stock symbol to view the stock details.